title: A randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancer.
authors.affiliation: Department of Gynecologic Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-City, Saitama 350-1298, Japan. fujiwara@saitama-med.ac.jp
authors.forename: Keiichi
authors.initials: K
authors.lastname: Fujiwara
authors.forename: Eriko
authors.initials: E
authors.lastname: Aotani
authors.forename: Tetsutaro
authors.initials: T
authors.lastname: Hamano
authors.forename: Shoji
authors.initials: S
authors.lastname: Nagao
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Yoshikawa
authors.forename: Toru
authors.initials: T
authors.lastname: Sugiyama
authors.forename: Junzo
authors.initials: J
authors.lastname: Kigawa
authors.forename: Daisuke
authors.initials: D
authors.lastname: Aoki
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Katsumata
authors.forename: Masahiro
authors.initials: M
authors.lastname: Takeuchi
authors.forename: Mitsuaki
authors.initials: M
authors.lastname: Suzuki